ALSO NOTED: EU committee recommends Parkinson's therapy; Actavis to close warehouse; and much more...

> The European Committee for Medical Products for Human Use has recommended that Schwarz Pharma's Neupro patch be approved for use against Parkinson's. Report

> The CHMP has recommended Novartis AG's Exforge hypertension drug and Lucentis treatment for blindness. Report

> The Committee for Medicinal Products for Human Use also concluded that Tamiflu does not pose a health risk. Report

> Actavis Group is closing a warehouse in Maryland. Report

And Finally...The CDC has significantly revamped the way it cares for lab animals. Article

Suggested Articles

Bausch Health is paying $10 million upfront for the option to acquire Allegro Ophthalmics’ eye disease assets, with a promise of $40 million to come.

Anthony Coyle, Ph.D., has signed up to run Repertoire Immune Medicines’ R&D.

The IPO haul will set Kronos up to start a registrational phase 2/3 trial of a first-line AML drug licensed from Bischofberger's former employer.